NCT07182149
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07182149
Title A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Normunity AccelCo, Inc.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Normunity Investigational Site RECRUITING Denver Colorado 80220 United States Details
Normunity Investigational Site RECRUITING New Haven Connecticut 06519 United States Details
Normunity Investigational Site RECRUITING Minneapolis Minnesota 55425 United States Details
Normunity Investigational Site RECRUITING Maumee Ohio 43537 United States Details
Normunity Investigational Site RECRUITING Philadelphia Pennsylvania 19107 United States Details
Normunity Investigational Site RECRUITING Nashville Tennessee 37203 United States Details
Normunity Investigational Site RECRUITING Dallas Texas 75230 United States Details
Normunity Investigational Site RECRUITING San Antonio Texas 78229 United States Details
Normunity Investigational Site RECRUITING Fairfax Virginia 22031 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field